Coty Inc. is a global beauty company that specializes in the development, manufacturing, and marketing of a wide range of beauty products, including perfumes, cosmetics, and skincare solutions
With a diverse portfolio that includes both established and emerging brands, Coty aims to enhance the beauty experience for consumers through innovative and high-quality offerings. The company focuses on creating iconic fragrances, cutting-edge makeup products, and luxurious skincare treatments, catering to a variety of customer preferences and market segments. Through its commitment to sustainability and social responsibility, Coty continues to evolve its product lines and business practices to meet the changing needs of consumers around the world.
Stifel analyst Mark S. Astrachan lowered Coty's price target from $8.5 to $8, maintaining a Hold rating. Despite adjusted EBITDA growth, Coty's second-quarter FY25 results revealed a 1% YoY decline in net revenue and a challenging outlook for the second half of FY25.
Beauty products company Coty (NYSECOTY) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 3.3% year on year to $1.67 billion. Its non-GAAP profit of $0.11 per share was 47.7% below analysts’ consensus estimates.
What a brutal six months it’s been for Coty. The stock has dropped 31.4% and now trades at $6.83, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. On the other hand, they usually underperform during bull runs,
but the sector has bucked this trend lately as its six-month return of 6.9% has closely followed the S&P 500.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with Coty (NYSECOTY).
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Nov. 4-8, 2024.
Beauty products company Coty (NYSECOTY) met Wall Street’s revenue expectations in Q3 CY2024, with sales up 1.8% year on year to $1.67 billion. Its non-GAAP profit of $0.15 per share was 18.3% below analysts’ consensus estimates.
